Skip to main content

Peer Review reports

From: Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil

Original Submission
26 Sep 2022 Submitted Original manuscript
22 Dec 2022 Reviewed Reviewer Report
2 Jan 2023 Reviewed Reviewer Report
4 Jan 2023 Reviewed Reviewer Report
28 Feb 2023 Author responded Author comments - Ricardo Sobhie Diaz
Resubmission - Version 2
28 Feb 2023 Submitted Manuscript version 2
31 Mar 2023 Reviewed Reviewer Report
4 Apr 2023 Reviewed Reviewer Report
22 Apr 2023 Author responded Author comments - Ricardo Sobhie Diaz
Resubmission - Version 3
22 Apr 2023 Submitted Manuscript version 3
Publishing
27 Apr 2023 Editorially accepted
24 May 2023 Article published 10.1186/s12879-023-08288-8

You can find further information about peer review here.

Back to article page